NRMX : from C/W's Shulman BioTechBlitz Blog
His most recent blog entry is, "Investing In a Disease" :
Posted by Michael Shulman, C/W's BioTech newsletter editor, on his BioTechBlitz Blog on May 14, 2007
( There is on reader comment at the bottom of the webpage asking about Geron posted by Concerned Person )
biotechblitz.com
Here is an archived list of Shulman post on his blog:
biotechblitz.com
Some examples:
March 2007: Disease Overview: Diabetes and Patient Convenience
biotechblitz.com
It appears he closed his Neurochem ( NRMX ) position in Feb 2007:
biotechblitz.com
March 2007: Vaccines – Boring, Profitable, Evergreen
biotechblitz.com
includes:
..."leading vaccine company in the world is GlaxoSmithKline, but given its size, this new business will not push it into double-digit growth, The real winners in this market will be those companies developing new vaccines and new vaccine manufacturing technology. Companies to watch include Iomai (IOMI), Acambis (ACAM) and Crucell (CRXL)"....
NOTE: re NRMX
Shulman may have NRMX in his ChangeWave Shorts newsletter. Using a regular Site Search, not the advanced Site Search, NRMX may have been mentioned in the following ---
05/17/2007 Stocks Not Even a Mother Could Love
05/09/2007 Why I Love the Short Side |
